Compare · GATX vs SRTA
GATX vs SRTA
Side-by-side comparison of GATX Corporation (GATX) and Strata Critical Medical Inc. (SRTA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GATX and SRTA operate in Transportation Services (Consumer Discretionary), so they compete in similar markets.
- GATX is the larger of the two at $6.12B, about 12.0x SRTA ($507.9M).
- Over the past year, GATX is up 9.8% and SRTA is up 38.5% - SRTA leads by 28.7 points.
- SRTA has been more active in the news (3 items in the past 4 weeks vs 2 for GATX).
- GATX has more recent analyst coverage (16 ratings vs 3 for SRTA).
PerformanceGATX+9.77%SRTA+38.52%
2025-06-09+0.00%2026-06-08
- Company
- GATX Corporation
- Strata Critical Medical Inc.
- Price
- $172.46+0.74%
- $5.88+1.91%
- Market cap
- $6.12B
- $507.9M
- 1M return
- -5.77%
- +9.91%
- 1Y return
- +9.77%
- +38.52%
- Industry
- Transportation Services
- Transportation Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 2
- 3
- Recent ratings
- 16
- 3
GATX
GATX Corporation
GATX Corporation (NYSE: GATX) strives to be recognized as the finest railcar leasing company in the world by our customers, our shareholders, our employees and the communities where we operate. As the leading global railcar lessor, GATX has been providing quality railcars and services to its customers for more than 122 years. GATX has been headquartered in Chicago, Illinois since its founding in 1898.
Latest GATX
- GATX Corporation to Present at the Wells Fargo 16th Industrials and Materials Conference
- GATX Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form S-8 filed by GATX Corporation
- SEC Form 10-Q filed by GATX Corporation
- GATX Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- GATX Corporation Reports 2026 First-Quarter Results
- Director Holmes John Mcclain Iii was granted 129 shares, increasing direct ownership by 3% to 4,321 units (SEC Form 4)
- Director Bausch Shelley J was granted 128 shares, increasing direct ownership by 3% to 4,165 units (SEC Form 4)
- Director Wetherbee Robert S was granted 115 shares, increasing direct ownership by 8% to 1,515 units (SEC Form 4)
- Director Yovovich Paul G was granted 136 shares, increasing direct ownership by 0.32% to 42,289 units (SEC Form 4)
Latest SRTA
- Strata Critical Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Strata Acquires Louisville Perfusion Services
- Chief Accounting Officer Cohen Amir sold $299,435 worth of shares (50,875 units at $5.89) as part of a pre-agreed trading plan, decreasing direct ownership by 25% to 151,263 units (SEC Form 4)
- Chief Accounting Officer Cohen Amir sold $82,832 worth of shares (14,306 units at $5.79) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 202,138 units (SEC Form 4)
- AIAI Holdings Corporation Announces Appointment of Board of Directors
- SEC Form 4 filed by Large owner Krstic Velibor
- Strata Critical Medical Announces Expiration of Warrants
- SEC Form 25-NSE filed by Strata Critical Medical Inc.
- SEC Form 10-Q filed by Strata Critical Medical Inc.
- Strata Critical Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits